Standardization of analysis sets for reporting results from ADNI MRI data 27 October 2012 Abstract: “The Alzheimer’s Disease Neuroimaging Initiative (ADNI) three-dimensional T(1)-weighted magnetic resonance imaging (MRI) acquisitions provide a rich data set for developing and testing analysis techniques for extracting structural endpoints.... Read More>
ADNI: A review of papers published since its inception 21 November 2011 Access the full article on PubMed Title: The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception Authors: Weiner MW, Veitch DP, Aisen PS, Beckett LA,... Read More>
ADNI: progress report and future plans. 21 May 2010 “The Alzheimer’s Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-year research project that studies changes of cognition, function, brain structure and function, and biomarkers in elderly... Read More>
Update on the Biomarker Core of ADNI subjects 21 May 2010 “Here, we review progress by the Penn Biomarker Core in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) toward developing a pathological cerebrospinal fluid (CSF) and plasma biomarker signature for mild... Read More>
Clinical Core of ADNI: progress and plans 21 May 2010 “The Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) has provided clinical, operational, and data management support to ADNI since its inception. This article reviews the activities and... Read More>
Update on the magnetic resonance imaging core of ADNI 10 May 2010 “Functions of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) magnetic resonance imaging (MRI) core fall into three categories: (1) those of the central MRI core laboratory at Mayo Clinic, Rochester,... Read More>
ADNI: MRI Methods 21 April 2008 “Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquired at multiple time points. All... Read More>
